Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Rusckowski

Quest Diagnostics has appointed Stephen Rusckowski as the chairman of its board of directors. Rusckowski succeeds Daniel Stanzione, who will be staying on as lead independent director. Rusckowski joined Quest in 2012 and continues to serve as president and CEO.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.